Radhika Tripuraneni

Chief Development Officer, PROTHENA CORP PUBLIC LTD CO.

Companies

Viridian Therapeutics, Inc.\DEChief Medical Officer Mar 12, 2025 to now¹
Terns Pharmaceuticals, Inc.Board member Jul 28, 2022 to now²
PROTHENA CORP PUBLIC LTD COChief Development Officer Dec 13, 2018 to Feb 25, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Viridian Therapeutics, Inc.\DE VRDN40,000 shares⁴$828.8K at $20.72Aug 14, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 14, 2026Exercised options 40,000 shares at $13.21 of Viridian Therapeutics, Inc.\DE⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARViridian Therapeutics, Inc.\DE, Chief Medical Officer
2
SEC EDGARTerns Pharmaceuticals, Inc., Board member
3
SEC EDGARPROTHENA CORP PUBLIC LTD CO, Chief Development Officer
4
SEC EDGARViridian Therapeutics, Inc.\DE shares after the filing of Aug 14, 2026